Showing 801 - 820 results of 3,136 for search '"Diabetes mellitus"', query time: 0.13s Refine Results
  1. 801
  2. 802

    Ocular TGF-β, Matrix Metalloproteinases, and TIMP-1 Increase with the Development and Progression of Diabetic Retinopathy in Type 2 Diabetes Mellitus by Lucia Saucedo, Isabel B. Pfister, Souska Zandi, Christin Gerhardt, Justus G. Garweg

    Published 2021-01-01
    “…Diabetic retinopathy (DR) is a sight-threatening late complication of diabetes mellitus (DM). Even though its pathophysiology has not been fully elucidated, several studies suggested a role for transforming growth factor- (TGF-) β, matrix metalloproteinases (MMPs), and tissue inhibitors of matrix metalloproteinase (TIMP) in the onset and progression of the disease. …”
    Get full text
    Article
  3. 803
  4. 804

    Effect of Combination Therapy of Canagliflozin Added to Teneligliptin Monotherapy in Japanese Subjects with Type 2 Diabetes Mellitus: A Retrospective Study by Yoshiro Fushimi, Atsushi Obata, Junpei Sanada, Yuichiro Iwamoto, Akiko Mashiko, Megumi Horiya, Akiko Mizoguchi-Tomita, Momoyo Nishioka, Yuki Kan, Tomoe Kinoshita, Seizo Okauchi, Hidenori Hirukawa, Kenji Kohara, Fuminori Tatsumi, Masashi Shimoda, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto

    Published 2020-01-01
    “…Recently, dipeptidyl peptidase-4 (DPP-4) inhibitors and sodium-glucose cotransporter 2 (SGLT2) inhibitors have been very often used in subjects with type 2 diabetes mellitus (T2DM). In addition, combination drugs of both inhibitors have attracted much attention in aspects of its cost-effectiveness and improvement of patients’ adherence. …”
    Get full text
    Article
  5. 805
  6. 806

    Effect of Admission Hyperglycemia on Short-Term Prognosis of Patients with Non-ST Elevation Acute Coronary Syndrome without Diabetes Mellitus by Wei Liu, Zhijuan Li, Shiying Xing, Yanwei Xu

    Published 2021-01-01
    “…To evaluate the effect of admission hyperglycemia on the short-term prognosis of patients with non-ST elevation acute coronary syndrome (NSTE-ACS) without diabetes mellitus. Methods. The clinical data of 498 patients with NSTE-ACS admitted to the Department of Cardiology of the First Affiliated Hospital of Henan University of Science and Technology between March 2018 and November 2020 were analyzed. …”
    Get full text
    Article
  7. 807
  8. 808

    Coronary Heart Disease in Postmenopausal Women with Type II Diabetes Mellitus and the Impact of Estrogen Replacement Therapy: A Narrative Review by Marouane Boukhris, Salvatore Davide Tomasello, Francesco Marzà, Sonia Bregante, Francesca Romana Pluchinotta, Alfredo Ruggero Galassi

    Published 2014-01-01
    “…Coronary heart disease is the main cause of death in postmenopausal women (PMW); moreover its mortality exceeds those for breast cancer in women at all ages. Type II diabetes mellitus is a major cardiovascular risk factor and there is some evidence that the risk conferred by diabetes is greater in women than in men. …”
    Get full text
    Article
  9. 809
  10. 810

    Expression of atherosclerosis-associated genes in peripheral blood of drug-naïve hypertensive subjects with newly-diagnosed type 2 diabetes mellitus by Nikolay Stoynev, Ivanka Dimova, Blaga Rukova, Savina Hadjidekova, Dragomira Nikolova, Tsvetalina Tankova

    Published 2025-02-01
    “…Aim: To evaluate the expression of atherosclerosis-associated genes in peripheral blood of drug-naïve hypertensive subjects with newly-diagnosed type 2 diabetes mellitus. Materials and methods: Eighteen subjects (15 males, 3 females), mean age 46.27 ± 12.07 years, divided into two groups: studied group - subjects with newly-diagnosed hypertension and newly-diagnosed type 2 diabetes (n = 9), control group – normotensive individuals with newly-diagnosed type 2 diabetes (n = 9) Gene expression analysis was performed with Human Atherosclerosis RT2 Profiler PCR Array. …”
    Get full text
    Article
  11. 811

    Correlation of Glucose and Lipid Metabolism Levels and Serum Uric Acid Levels with Diabetic Retinopathy in Type 2 Diabetic Mellitus Patients by Tiantian Li, Yan Wu

    Published 2022-01-01
    “…The aim of this study was to observe the association between the development of diabetic retinopathy (DR) in type 2 diabetes mellitus (T2DM) and the levels of glucose and lipid metabolism and serum uric acid (SUA) levels. …”
    Get full text
    Article
  12. 812
  13. 813
  14. 814
  15. 815
  16. 816
  17. 817

    Effects of Semaglutide Treatment on Psoriatic Lesions in Obese Patients with Type 2 Diabetes Mellitus: An Open-Label, Randomized Clinical Trial by Jelena Petković-Dabić, Ivana Binić, Bojana Carić, Ljiljana Božić, Sanja Umičević-Šipka, Nataša Bednarčuk, Saša Dabić, Mirna Šitum, Snježana Popović-Pejičić, Miloš P. Stojiljković, Ranko Škrbić

    Published 2025-01-01
    “…The objective of this clinical study was to investigate the effect of GLP-1 receptor agonist semaglutide therapy on pro-inflammatory factors in the serum and the severity of the clinical picture of psoriasis in obese patients with type 2 diabetes mellitus (T2DM) on chronic metformin therapy. …”
    Get full text
    Article
  18. 818

    Glucometabolic-Related Genes as Diagnostic Biomarkers and Therapeutic Targets for Alzheimer’s Disease and Type 2 Diabetes Mellitus: A Bioinformatics Analysis by Shuo Liu, He Chen, Xiao-Dong He, Xiao-Ou Yang

    Published 2024-01-01
    “…Alzheimer’s disease (AD) and type 2 diabetes mellitus (T2DM) are two widespread chronic disorders characterized by shared risk factors and molecular pathways. …”
    Get full text
    Article
  19. 819
  20. 820